Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Addus HomeCare Corp. (NASDAQ: ADUS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the information. Addus HomeCare is a Delaware corporation based in Frisco, Texas that provides personal care, hospice and home health services, and its filings offer detailed insight into this business.
Investors can use this page to access periodic and current reports where the company discusses its operations, financial condition and governance. Form 8-K filings, for example, are used by Addus HomeCare to report events such as quarterly earnings announcements, annual meeting voting results and acquisition-related updates. Recent 8-K and 8-K/A filings describe the company’s results of operations for specific quarters, the completion and financial reporting of the Gentiva personal care acquisition and the outcomes of its 2025 annual meeting of stockholders.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available through EDGAR) typically contain segment information for personal care, hospice and home health, along with discussions of payor mix, reimbursement exposure and risk factors. For a home health care services company like Addus HomeCare, these filings are central to understanding how government programs, managed care organizations and other payors affect revenue.
On Stock Titan, AI-generated summaries are designed to highlight key points from lengthy filings, such as changes in segment performance, updates on acquisitions, or governance decisions disclosed in proxy-related materials. Users can also review exhibits referenced in 8-K filings, including earnings press releases that are incorporated by reference. This page further facilitates monitoring of executive and director matters disclosed in meeting results and other governance-related filings.
By combining real-time EDGAR updates with AI explanations, the Addus HomeCare SEC filings page helps readers navigate complex regulatory documents, from 10-K and 10-Q reports to 8-K and 8-K/A filings, and understand how these disclosures relate to the company’s home-based care operations.
Addus HomeCare Corp executive Monica Raines reported planned stock sales tied to tax obligations. She sold 437 shares of common stock on February 24, 2026 at $106.99 per share and 219 shares on February 25, 2026 at $105.36 per share in open-market transactions.
The filing states these sales were made under a previously established Rule 10b5-1 trading plan to satisfy taxes owed upon the vesting of restricted stock awards. After these transactions, she directly owns 13,801 shares of Addus HomeCare common stock.
Addus HomeCare Corp executive Roberton James Stevenson reported two open-market sales of common stock under a pre-set 10b5-1 plan. He sold 567 shares on February 24, 2026 at
Addus HomeCare Corp executive Cliff Donald Blessing reported open-market sales of company stock. He sold 350 shares on February 24 at $107.14 per share and 177 shares on February 25 at $105.36 per share. These transactions were made under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from vesting restricted stock awards. After these sales, he directly owns 12,361 common shares.
Addus HomeCare Corp executive Michael D. Wattenbarger, EVP and Chief Information Officer, reported selling 892 shares of common stock in two open-market transactions. He sold 592 shares at $107.35 per share and 300 shares at $105.36 per share, all classified as direct ownership.
According to the filing, these sales were made under a previously established Rule 10b5-1 trading plan and were undertaken to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. After these transactions, Wattenbarger directly holds 9,444 shares of Addus common stock.
Addus HomeCare Corp executive David W. Tucker reported selling company stock in two open-market transactions. As EVP and Chief Strategy Officer, he sold 704 shares of common stock on February 24 at $107.35 per share and 379 shares on February 25 at $105.36 per share.
These sales, totaling 1,083 shares, were made pursuant to a previously established Rule 10b5-1 trading plan to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. Following the most recent sale, Tucker directly holds 10,423 shares of Addus common stock.
Addus HomeCare Corp executive Anderson Darby reported small planned stock sales under a Rule 10b5-1 plan. On
Addus HomeCare Corp executive Sean Gaffney, EVP and Chief Legal Officer, reported selling 1,259 shares of common stock in open-market transactions under a previously established Rule 10b5-1 trading plan.
The sales occurred on February 24 and 25, 2026, at prices of $106.98 and $105.36 per share. According to the disclosure, the trades were made to satisfy tax obligations arising from the vesting of restricted stock awards. After these transactions, Gaffney directly owned 20,080 shares of Addus common stock.
Addus HomeCare Corp EVP and CFO Brian Poff reported open-market sales of 2,861 shares of common stock. The transactions occurred on two days, involving 2,041 shares on one day and 820 shares on the next, at prices a little above $105 per share. According to the footnotes, these sales were executed under a previously established Rule 10b5-1 trading plan and were made to cover tax obligations arising from the vesting of restricted stock awards. After these sales, Poff continues to hold 63,692 shares of Addus HomeCare common stock directly.
Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions. He sold 4,988 shares at an average price of $106.98 on February 24 and 2,364 shares at $105.36 on February 25. These sales were made under a previously established Rule 10b5-1 trading plan to cover tax obligations from vesting restricted stock awards. After the transactions, he directly owns 183,150 shares of Addus HomeCare common stock.
Addus HomeCare Corporation reports strong expansion as a multi-segment home care provider focused on personal care, hospice and home health services. For the year ended December 31, 2025, total net service revenue rose to $1,422,530,000 from $1,154,599,000, while net income increased to $95,910,000 from $73,598,000.
The company served about 107,000 consumers across 23 states through roughly 262 offices, with a model centered on mostly dual-eligible Medicare/Medicaid patients and growing relationships with managed care organizations. Growth comes from both organic initiatives and acquisitions; six deals completed in 2024–2025 added meaningful revenue. Addus highlights opportunities from aging demographics, home- and community-based services demand and industry consolidation, while also warning about significant regulatory, Medicaid funding, labor cost and macroeconomic risks that could pressure margins and growth.